Eco Animal Health (GB:EAH) has released an update.
ECO Animal Health Group PLC, a leader in veterinary pharmaceuticals, has announced the granting of nominal cost share options to two of its Executive Directors, as a part of their annual bonus deferral scheme. A total of 143,452 ordinary shares were awarded to the CEO David Hallas and CFO Chris Wilks, which represents about 0.21% of the company’s issued share capital. These options, part of the company’s Deferred Bonus Plan, are set to vest after a period of three years.
For further insights into GB:EAH stock, check out TipRanks’ Stock Analysis page.
